The SMN2 gene can potentially express sufficient functional SMN protein to fully compensate for the loss of SMN1 in all patients with SMA, which makes it an attractive target for drug therapy. The development of therapeutic approaches would be greatly facilitated by precise knowledge of the mechanis...